Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations

References

• Brune K, Schweitzer A, Lanz R. Importance of drug biodistribution andmetabolism in the development of side effects by anti-inflammatory/analgesic drugs. In: Rainsford KD, Velo GP, eds. Advances in inflammation research. 6th ed. New York: Raven Press; 1984:35–42
   Google Scholar
• Adams SS. NSAIDs plasma half-lives, and adverse drug reactions. Lancet 1988;1:653–4
   PubMedGoogle Scholar
• Weber JCP. Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP, eds. Advances in inflammation research. 6th ed. New York: Raven Press; 1984:1–7
   Google Scholar
• Bensen WG, Fiechtner JJ, McMillaen JI. Treatment of osteoarthritis with celecoxib, acyclooxygenase-2 inhibitor; a randomized controlled trial. Mayo Clin Proc 1999;74:1095–105
   PubMed Web of Science ®Google Scholar
• Day R, Morrison B, Luza A, et al. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs. ibuprofen in patients with osteoarthritis. Arch Intern Med 2000;160:1781–7
   PubMed Web of Science ®Google Scholar
• Emery P, Zeidler H, Kvien T. Celecoxib versus diclofenac in long term treatment of rheumatoid arthritis: randomized double blind comparison. Lancet 1999;354:2106–11
   PubMed Web of Science ®Google Scholar
• Stichtenoth DO, Frolich JC. The second generation of COX-2 inhibitors. Drugs 2003;63:33–45
   PubMed Web of Science ®Google Scholar
• Kato M, Nishida S, Kitasato H, et al. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of nonsteroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 2001;53:1679–85
   PubMed Web of Science ®Google Scholar
• Bawkey, CJ. COX-2 inhibitors. Lancet 1999;353:307–14
   PubMedGoogle Scholar
• Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol 1997;24:6–8
   PubMedGoogle Scholar
• Coppelli G, Guaita E, Spaggiari S, Coruzzi G. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat. Dig Liver Dis 2004;36:265–70
   PubMedGoogle Scholar
• Kaur K, Jain S, Sapra B, Tiwary A. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Curr Drug Deliv 2007;4:276–82
   PubMedGoogle Scholar
• Subramanian N, Ghosal SK, Moulik SP. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev Ind Pharm 2005;31:405–16
   PubMed Web of Science ®Google Scholar
• Baboota S, Shakeel F, Ahuja A, et al. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm 2007;57:315–32
   PubMedGoogle Scholar
• Charoo NA, Shamsher AAA, Kohli K, et al. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil. Colloids Surf B Biointerfaces 2008;65:300–7
   PubMed Web of Science ®Google Scholar
• Soliman SM, Abdel Malak NS, El-Gazayerly ON, Abdel Rehim AA. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: in vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther 2010;4:459–71
   PubMedGoogle Scholar
• Walters KA. Percutaneous absorption and transdermal therapy. Pharm Tech 1986;10:30–42
   Google Scholar
• Yamane MA, Williams AC, Barry BW. Terpene penetration enhancers in propylene glycol/water cosolvent systems. Effectiveness and mechanism of action. J Pharm Pharmacol 1995;47:978–89
   PubMed Web of Science ®Google Scholar
• Gao S, Singh J. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J Control Release 1998;51:193–9
   PubMed Web of Science ®Google Scholar
• Kobayashi D, Matsuzawar T, Sugibayashi K, et al. Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with 1-mentho-ethanol system on hairless rat and human skin. Biol Pharm Bull 1993;16:254–8
   PubMed Web of Science ®Google Scholar
• Cornwell PA, Barry BW. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int J Pharm 1993;94:189–94
   Web of Science ®Google Scholar
• E1-Kattan AF, Asbill CS, Kim N, Michniak BB. The effect of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm 2001;215:229–40
   PubMedGoogle Scholar
• Williams AC, Barry BW. Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 1992;9:305–53
   PubMed Web of Science ®Google Scholar
• Institutional animal care and use committee guidebook. Applied research ethics national association. 2nd ed. Bethesda (MD): Office of laboratory animal welfare, National Institutes of Health; 2002
   Google Scholar
• Food and Drug Administration. Guidance for industry bioanalytical method validation. Rockville (MD): FDA; 2001
   Google Scholar
• Pharmacokinetic Software. Available from: http://www.boomer.org/pkin/soft.html [last accessed 29 July 2012]
   Google Scholar
• Singh GB, Singh S, Bani S. Anti-inflammatory actions of boswellic acids. Phytomedicine 1996;3:81–5
   PubMed Web of Science ®Google Scholar
• Leiva IM, Emmert-Buck MR, Gillespie JW. Handling of clinical tissue specimens for molecular profiling studies. Curr Issues Mol Biol 2003;5:27–35
   PubMedGoogle Scholar
• Afouna MI, Fincher TK, Khan MA, Reddy IK. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective. Chirality 2003;15:456–65
   PubMed Web of Science ®Google Scholar
• Cornwell PA, Barry BW, Bouwstra JA, Gooris GS. Modes of action of terpene penetration enhancers in human skin differential scanning calorimetery, small angle X-ray diffraction and enhancer uptake studies. Int J Pharm 1996;127:9–26
   Web of Science ®Google Scholar
• Ogiso T, Iwaki M, Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, relationship between penetration parameters and enhancement factors. J Pharm Sci 1995;84:482–8
   PubMed Web of Science ®Google Scholar
• Fox LT, Gerber M, Plessis JD, Hamman JH. Transdermal drug delivery enhancement by compounds of natural origin. Molecules 2011;16:10507–40
   Web of Science ®Google Scholar
• Masten S, Haneke KE. Turpentine: review of toxicological literature. Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2002
   Google Scholar
• Williams AC, Barry BW. Terpenes and lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res 1991;8:17–24
   PubMed Web of Science ®Google Scholar
• Baker EJ, Hadgraft J. In vitro percutaneous absorption of arildone, a highly lipophilic drug, and the apparent no-effect of the penetration enhancer azone in excised human skin. J Pharm Res 1995;12:993–7
   PubMed Web of Science ®Google Scholar
• Santoyo S, Arellano A, Ygartua P, Martin C. Penetration enhancer effects on the invitro percutaneous absorption of piroxicam through rat skin. Int J Pharm 1995;117:219–24
   Web of Science ®Google Scholar
• Guo JH. Carbopol® polymers for pharmaceutical drug delivery applications. Drug Dev Deli 2003;3(6). Available from: http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=4&id=C691909D749749438ABEF792F1A24A69 [last accessed 29 July 2012]
   Google Scholar
• French DL, Häglund BO, Himmelstein KJ, Mauger JW. Controlled release of substituted benzole and naphthoic acids using Carbopol® gels: measurement of drug concentration profiles and correlation to release rate kinetics. Pharm Res 1995;12:1513–20
   PubMed Web of Science ®Google Scholar
• Iglesias RB, Lorenzo CA, Concheiro A. Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. J Control Release 2001;77:59–75
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration. Available from: http://www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm [last accessed 29 July 2012]
   Google Scholar
• Paulson SK, Zhang JY, Breau AP. Pharmacokinetics, tissue distribution, metabolism and excretion of celecoxib in rats. Drug Metab Disp 2000;28:514–21
   PubMed Web of Science ®Google Scholar
• Lashmar UT, Hadgraft J, Thomas N. Topical application of penetration enhancers to the skin of nude mice: a histological study. J Pharm Pharmacol 1989;41:118–21
   PubMed Web of Science ®Google Scholar
• Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci 1998;95:13313–18
   PubMed Web of Science ®Google Scholar